224 related articles for article (PubMed ID: 37950308)
1. Rapid profiling of Plasmodium parasites from genome sequences to assist malaria control.
Phelan JE; Turkiewicz A; Manko E; Thorpe J; Vanheer LN; van de Vegte-Bolmer M; Ngoc NTH; Binh NTH; Thieu NQ; Gitaka J; Nolder D; Beshir KB; Dombrowski JG; Di Santi SM; Bousema T; Sutherland CJ; Campino S; Clark TG
Genome Med; 2023 Nov; 15(1):96. PubMed ID: 37950308
[TBL] [Abstract][Full Text] [Related]
2. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N
Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal.
Ranjitkar S; Schousboe ML; Thomsen TT; Adhikari M; Kapel CM; Bygbjerg IC; Alifrangis M
Malar J; 2011 Apr; 10():75. PubMed ID: 21457533
[TBL] [Abstract][Full Text] [Related]
5. Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India.
Rana R; Khan N; Sandeepta S; Pati S; Das A; Bal M; Ranjit M
Malar J; 2022 Dec; 21(1):394. PubMed ID: 36566182
[TBL] [Abstract][Full Text] [Related]
6. UK malaria treatment guidelines.
Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
[TBL] [Abstract][Full Text] [Related]
7. Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu.
Kinzer MH; Chand K; Basri H; Lederman ER; Susanti AI; Elyazar I; Taleo G; Rogers WO; Bangs MJ; Maguire JD
Malar J; 2010 Apr; 9():89. PubMed ID: 20370920
[TBL] [Abstract][Full Text] [Related]
8. Malaria Surveillance - United States, 2015.
Mace KE; Arguin PM; Tan KR
MMWR Surveill Summ; 2018 May; 67(7):1-28. PubMed ID: 29723168
[TBL] [Abstract][Full Text] [Related]
9. Geographical emergence of sulfadoxine-pyrimethamine drug resistance-associated
Nkemngo FN; Raissa LW; Nguete DN; Ndo C; Fru-Cho J; Njiokou F; Wanji S; Wondji CS
Antimicrob Agents Chemother; 2023 Dec; 67(12):e0058823. PubMed ID: 37947766
[TBL] [Abstract][Full Text] [Related]
10. Proteomic approaches to studying drug targets and resistance in Plasmodium.
Cooper RA; Carucci DJ
Curr Drug Targets Infect Disord; 2004 Mar; 4(1):41-51. PubMed ID: 15032633
[TBL] [Abstract][Full Text] [Related]
11. Nationwide Monitoring for Plasmodium falciparum Drug-Resistance Alleles to Chloroquine, Sulfadoxine, and Pyrimethamine, Haiti, 2016-2017.
Rogier E; Herman C; Huber CS; Hamre KES; Pierre B; Mace KE; Présumé J; Mondélus G; Romilus I; Elismé T; Eisele TP; Druetz T; Existe A; Boncy J; Lemoine JF; Udhayakumar V; Chang MA
Emerg Infect Dis; 2020 May; 26(5):902-909. PubMed ID: 32310062
[TBL] [Abstract][Full Text] [Related]
12. Local emergence in Amazonia of
Mathieu LC; Cox H; Early AM; Mok S; Lazrek Y; Paquet JC; Ade MP; Lucchi NW; Grant Q; Udhayakumar V; Alexandre JS; Demar M; Ringwald P; Neafsey DE; Fidock DA; Musset L
Elife; 2020 May; 9():. PubMed ID: 32394893
[TBL] [Abstract][Full Text] [Related]
13. The drug sensitivity and transmission dynamics of human malaria on Nias Island, North Sumatra, Indonesia.
Fryauff DJ; Leksana B; Masbar S; Wiady I; Sismadi P; Susanti AI; Nagesha HS; Syafruddin ; Atmosoedjono S; Bangs MJ; Baird JK
Ann Trop Med Parasitol; 2002 Jul; 96(5):447-62. PubMed ID: 12194705
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia.
Marfurt J; Wirjanata G; Prayoga P; Chalfein F; Leonardo L; Sebayang BF; Apriyanti D; Sihombing MAEM; Trianty L; Suwanarusk R; Brockman A; Piera KA; Luo I; Rumaseb A; MacHunter B; Auburn S; Anstey NM; Kenangalem E; Noviyanti R; Russell B; Poespoprodjo JR; Price RN
Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():46-56. PubMed ID: 34193398
[TBL] [Abstract][Full Text] [Related]
15. Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.
Mekonnen SK; Aseffa A; Berhe N; Teklehaymanot T; Clouse RM; Gebru T; Medhin G; Velavan TP
Malar J; 2014 Jun; 13():244. PubMed ID: 24964730
[TBL] [Abstract][Full Text] [Related]
16. Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.
Dlamini SV; Beshir K; Sutherland CJ
Malar J; 2010 Mar; 9():68. PubMed ID: 20199676
[TBL] [Abstract][Full Text] [Related]
17. Drug resistance profile and clonality of Plasmodium falciparum parasites in Cape Verde: the 2017 malaria outbreak.
Da Veiga Leal S; Ward D; Campino S; Benavente ED; Ibrahim A; Claret T; Isaías V; Monteiro D; Clark TG; Gonçalves L; Valdez T; da Luz Lima Mendonça M; Silveira H; Nogueira F
Malar J; 2021 Mar; 20(1):172. PubMed ID: 33789667
[TBL] [Abstract][Full Text] [Related]
18. Malaria Surveillance - United States, 2018.
Mace KE; Lucchi NW; Tan KR
MMWR Surveill Summ; 2022 Sep; 71(8):1-35. PubMed ID: 36048717
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia.
Schunk M; Kumma WP; Miranda IB; Osman ME; Roewer S; Alano A; Löscher T; Bienzle U; Mockenhaupt FP
Malar J; 2006 Jul; 5():54. PubMed ID: 16817953
[TBL] [Abstract][Full Text] [Related]
20. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
Kolaczinski K; Durrani N; Rahim S; Rowland M
Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
